Eric Bateman

16.4k citations

80 papers · 4.5k indexed · h-index 32

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Physiology top 0.5%
- Asthma and respiratory diseases

Papers in ⓘ

Pulmonary and Respiratory Medicine 76
- Chronic Obstructive Pulmonary Disease (COPD) Research 67
- Respiratory Support and Mechanisms 22
- Inhalation and Respiratory Drug Delivery 16
- Respiratory and Cough-Related Research 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
Issues, ethics and legal aspects 2

Co-authors: Donald Banerji (10 shared papers)Klaus F. Rabe (3 shared papers)Dirk Bredenbröker (2 shared papers)Lesley Towse (3 shared papers)Peter Burney (6 shared papers)Michael Studnicka (5 shared papers)Dave Singh (8 shared papers)Gary T. Ferguson (4 shared papers)
Journals: European Respiratory Journal (16 papers)CHEST Journal (10 papers)Thorax (8 papers)Respiratory Medicine (5 papers)International Journal of COPD (3 papers)
Partner nations: South Africa United Kingdom United States

In The Last Decade

Eric Bateman

79 papers receiving 4.4k citations

Peers

Countries citing papers authored by Eric Bateman

Since Specialization

Citations

This map shows the geographic impact of Eric Bateman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Bateman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Bateman more than expected).

Fields of papers citing papers by Eric Bateman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Bateman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Bateman. The network helps show where Eric Bateman may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Bateman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Bateman Line = papers co-authored together Eric Bateman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	COPD in Never Smokers CHEST Journal ·Bernd Lamprecht, Mary Ann McBurnie, William M. Vollmer, Gunnar Guðmundsson, Tobias Welte, Ewa Niżankowska‐Mogilnicka, Michael Studnicka, Eric Bateman, Josep M. Antó, Peter Burney, David M. Mannino, Sonia Buist	2010	366
2	A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol CHEST Journal ·James F. Donohue, J.A. van Noord, Eric Bateman, Stephen J. Langley, Amanda Lee, Theodore J. Witek, Steven Kesten, Lesley Towse	2002	359
3	Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial The Lancet ·Klaus F. Rabe, Eric Bateman, Denis O’Donnell, Stephan Witte, Dirk Bredenbröker, Thomas D. Bethke	2005	355
4	Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE study European Respiratory Journal ·Eric Bateman, Gary T. Ferguson, Neil Barnes, Nicola Gallagher, Yulia Green, Michelle Henley, Donald Banerji	2013	314
5	Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4) European Respiratory Journal ·Roland Buhl, François Maltais, R Abrahams, Leif Bjermer, Eric Derom, Gary T. Ferguson, Matjaž Fležar, Jacques Hébert, Lorcan McGarvey, Emílio Pizzichini, Jim Reid, Antony Veale, Lars Grönke, Alan Hamilton, Lawrence Korducki, Kay Tetzlaff, Stella Waitere-Wijker, Henrik Watz, Eric Bateman	2015	245
6	Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study The Lancet Respiratory Medicine ·Claus Vogelmeier, Eric Bateman, John Pallante, Vijay Alagappan, Peter D’Andrea, Hungta Chen, Donald Banerji	2012	239
7	Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD European Respiratory Journal ·Richard N. van Zyl-Smit, Madhukar Pai, Wing Wai Yew, Chi Chiu Leung, Alimuddin Zumla, Eric Bateman, Keertan Dheda	2009	200
8	Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis Thorax ·Peter Burney, Anamika Jithoo, Bernet Kato, Christer Janson, David M. Mannino, Ewa Niżankowska‐Mogilnicka, Michael Studnicka, Wan C. Tan, Eric Bateman, Ali Kocabaş, William M. Vollmer, Thorarrin Gislason, Guy B. Marks, Parvaiz A Koul, Imed Harrabi, Louisa Gnatiuc, Sonia Buist, (unknown)	2013	160
9	Tuberculosis associates with both airflow obstruction and low lung function: BOLD results European Respiratory Journal ·André F.S. Amaral, Sonia Coton, Bernet Kato, Wan C. Tan, Michael Studnicka, Christer Janson, Þórarinn Gíslason, David M. Mannino, Eric Bateman, Sonia Buist, Peter Burney	2015	145
10	Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study European Respiratory Journal ·Paul Jones, Dave Singh, Eric Bateman, Àlvar Agustí, Rosa Lamarca, Gonzalo de Miquel, Rosa Segarra, Cynthia Caracta, Esther García Gil	2012	141
11	Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study BMC Pulmonary Medicine ·Dave Singh, Paul Jones, Eric Bateman, Stephanie Korn, Cristina Helena dos Reis Serra, Eduard Molins, Cynthia Caracta, Esther García Gil, Anne Leselbaum	2014	141
12	Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort The Lancet Respiratory Medicine ·Rupert Jones, David Price, Dermot Ryan, Erika Sims, Julie von Ziegenweidt, Laurence Mascarenhas, Anne Burden, David Halpin, Robert J. Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm, Eric Bateman	2014	136
13	Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison Thorax ·Donald A. Mahler, Anthony D’Urzo, Eric Bateman, Serir Aktoğu, Tracy White, Clare Peckitt, Cheryl Lassen, Benjamin Krämer, (unknown)	2012	126
14	A Systematic Review of the Association between Pulmonary Tuberculosis and the Development of Chronic Airflow Obstruction in Adults Respiration ·Brian Allwood, Landon Myer, Eric Bateman	2013	101
15	A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients Respiratory Medicine ·Eric Bateman, Donald P. Tashkin, Nikolaos M. Siafakas, Ronald Dahl, Lesley Towse, Dan Massey, D Pavia, Nanshan Zhong	2010	89
16	Roflumilast with long-acting β₂-agonists for COPD: influence of exacerbation history European Respiratory Journal ·Eric Bateman, Klaus F. Rabe, Peter M.A. Calverley, U. M. Goehring, Manja Brose, Dirk Bredenbröker, Leonardo M. Fabbri	2011	87
17	Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax ·Gary Maartens, Eric Bateman	1991	81
18	Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT) Respiratory Research ·Eric Bateman, Kenneth R. Chapman, Dave Singh, Anthony D’Urzo, Eduard Molins, Anne Leselbaum, Esther García Gil	2015	80
19	Hut lung: a domestically acquired pneumoconiosis of mixed aetiology in rural women. Thorax ·Johannes P Grobbelaar, Eric Bateman	1991	75
20	Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. PubMed ·Rod Dawson, P Masuka, David Edwards, Eric Bateman, Linda‐Gail Bekker, Robin Wood, S D Lawn	2010	72

About Eric Bateman

Eric Bateman is a scholar working on Pulmonary and Respiratory Medicine, Issues, ethics and legal aspects, Physiology, Emergency Medical Services and Cardiology and Cardiovascular Medicine, having authored 80 papers that have together received 4.5k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Asthma and respiratory diseases (33 papers), Respiratory Support and Mechanisms (22 papers), Inhalation and Respiratory Drug Delivery (16 papers), Respiratory and Cough-Related Research (9 papers), Health Promotion and Cardiovascular Prevention (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Pediatric health and respiratory diseases (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.6k citations), Physiology (2.5k citations), Issues, ethics and legal aspects (96 citations), Infectious Diseases (390 citations) and Emergency Medical Services (150 citations). Eric Bateman has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Donald Banerji, Klaus F. Rabe, Dirk Bredenbröker, Lesley Towse, Peter Burney, Michael Studnicka, Dave Singh, Gary T. Ferguson, Denis O’Donnell and Thomas D. Bethke. Their work appears in journals such as European Respiratory Journal, CHEST Journal, Thorax, Respiratory Medicine and International Journal of COPD.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact